312 related articles for article (PubMed ID: 8641367)
1. Activity of Friend mink cell focus-forming retrovirus during myelo-erythroid hematopoiesis.
Baum C; Eckert HG; Stocking C; Ostertag W
Exp Hematol; 1996 Feb; 24(2):364-70. PubMed ID: 8641367
[TBL] [Abstract][Full Text] [Related]
2. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.
Baum C; Hegewisch-Becker S; Eckert HG; Stocking C; Ostertag W
J Virol; 1995 Dec; 69(12):7541-7. PubMed ID: 7494260
[TBL] [Abstract][Full Text] [Related]
3. FMEV vectors: both retroviral long terminal repeat and leader are important for high expression in transduced hematopoietic cells.
Hildinger M; Eckert HG; Schilz AJ; John J; Ostertag W; Baum C
Gene Ther; 1998 Nov; 5(11):1575-9. PubMed ID: 9930313
[TBL] [Abstract][Full Text] [Related]
4. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.
Ketteler R; Glaser S; Sandra O; Martens UM; Klingmüller U
Gene Ther; 2002 Apr; 9(8):477-87. PubMed ID: 11948372
[TBL] [Abstract][Full Text] [Related]
5. High expression of transgenes mediated by hybrid retroviral vectors in hepatocytes: comparison of promoters from murine retroviruses in vitro and in vivo.
Ohnishi N; Itoh K; Itoh Y; Baum C; Higashitsuji H; Yamaguchi K; Tsuji T; Okanoue T; Fujita J
Gene Ther; 2002 Feb; 9(4):303-6. PubMed ID: 11896470
[TBL] [Abstract][Full Text] [Related]
6. Retroviral vector-mediated gene expression in human CD34+CD38- cells expanded in vitro: cis elements of FMEV are superior to those of Mo-MuLV.
Tsuji T; Itoh K; Baum C; Ohnishi N; Tomiwa K; Hirano D; Nishimura-Morita Y; Ostertag W; Fujita J
Hum Gene Ther; 2000 Jan; 11(2):271-84. PubMed ID: 10680841
[TBL] [Abstract][Full Text] [Related]
7. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
Green PL; Kaehler DA; McKearn J; Risser R
Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
[TBL] [Abstract][Full Text] [Related]
8. Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection.
Baum C; Eckert HG; Stockschläder M; Just U; Hegewisch-Becker S; Hildinger M; Uhde A; John J; Ostertag W
J Hematother; 1996 Aug; 5(4):323-9. PubMed ID: 8877707
[TBL] [Abstract][Full Text] [Related]
9. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses.
Ishimoto A; Takimoto M; Adachi A; Kakuyama M; Kato S; Kakimi K; Fukuoka K; Ogiu T; Matsuyama M
J Virol; 1987 Jun; 61(6):1861-6. PubMed ID: 3033317
[TBL] [Abstract][Full Text] [Related]
10. Autocrine transformation of human hematopoietic cells after transfection with an activated granulocyte/macrophage colony stimulating factor gene.
Hoyle PE; Steelman LS; McCubrey JA
Cytokines Cell Mol Ther; 1997 Sep; 3(3):159-68. PubMed ID: 9426974
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the Moloney murine leukemia virus stem cell-specific repressor binding site.
Kempler G; Freitag B; Berwin B; Nanassy O; Barklis E
Virology; 1993 Apr; 193(2):690-9. PubMed ID: 8460481
[TBL] [Abstract][Full Text] [Related]
12. Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat.
Faller DV; Weng H; Choi SY
Virology; 1997 Jan; 227(2):331-42. PubMed ID: 9018132
[TBL] [Abstract][Full Text] [Related]
13. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
Zhao-Emonet JC; Marodon G; Pioche-Durieu C; Cosset FL; Klatzmann D
J Gene Med; 2000; 2(6):416-25. PubMed ID: 11199262
[TBL] [Abstract][Full Text] [Related]
14. Role of the LTR region between the enhancer and promoter in mink cell focus-forming murine leukemia virus pathogenesis.
Yoshimura FK; Wang T
Virology; 2001 Apr; 283(1):121-31. PubMed ID: 11312668
[TBL] [Abstract][Full Text] [Related]
15. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
[TBL] [Abstract][Full Text] [Related]
16. Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice.
Greenberger JS; Newburger PE; Lipton JM; Moloney WC; Sakakeeny MA; Jackson PL
J Natl Cancer Inst; 1980 Apr; 64(4):867-78. PubMed ID: 6928998
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic cytokine-inducible gene expression from retroviral vectors.
Saylors RL; Stine KC; Derrick J
Gene Ther; 1999 May; 6(5):944-6. PubMed ID: 10505121
[TBL] [Abstract][Full Text] [Related]
18. Construction of retroviral vectors with enhanced efficiency of transgene expression.
Hahm SH; Yi Y; Lee DK; Noh MJ; Yun L; Hwang S; Lee KH
J Virol Methods; 2004 Nov; 121(2):127-36. PubMed ID: 15381349
[TBL] [Abstract][Full Text] [Related]
19. High frequency expression of integrated proviruses derived from enhancer trap retroviruses.
Sablitzky F; Jönsson JI; Cohen BL; Phillips RA
Cell Growth Differ; 1993 Jun; 4(6):451-9. PubMed ID: 8373730
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of replication competent retroviruses derived from mouse cells in immunosuppressed primates: implications for use of neoplastic cells as vaccine substrates.
Purcell DF
Dev Biol (Basel); 2001; 106():187-98; discussion 199, 253-63. PubMed ID: 11761231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
